- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Clinical Parotid Carcinoma Analysis
-
- Nagatani Gunji
- University of Occupational and Environmental Health
-
- Suzuki Hideaki
- University of Occupational and Environmental Health
-
- Mori Takanori
- University of Occupational and Environmental Health
-
- Koizumi Hiroki
- University of Occupational and Environmental Health
-
- Ohkubo Junichi
- University of Occupational and Environmental Health
-
- Ohbuchi Toyoaki
- University of Occupational and Environmental Health
-
- Wakasugi Tetsuro
- University of Occupational and Environmental Health
-
- Hohchi Nobusuke
- University of Occupational and Environmental Health
-
- Udaka Tsuyoshi
- University of Occupational and Environmental Health
Bibliographic Information
- Other Title
-
- 耳下腺癌48例の臨床統計
- 臨床 耳下腺癌48例の臨床統計
- リンショウ ジカセンガン 48レイ ノ リンショウ トウケイ
Search this article
Description
We clinically analyzed 48 consecutive retrospective cases of parotid carcinoma initially treated between 1988 and 2007. Subjects were 30 males and 18 females ranging from 5 to 85 years old (average: 57.9 years). Of the 12 histological types seen, the most common was mucoepidermoid carcinoma, seen in 12 subjects (25.0%). We studied their survival based on 5 potential prognostic factors-stage, T stage, neck metastasis, facial nerve palsy, and malignancy grade-together with features of mortality and recurrence.<br> Overall 5-year disease-specific survival was 71.2% and 10-year survival 54.9%.<br> Survival rates were significantly lower in stage IV and high-grade malignancy groups than in stage I-III and low-grade malignancy groups. T stage, neck metastasis, and facial nerve palsy tended to compromise survival. Recurrence developed in 2 subjects, in whom significant recurrence risk factors were stage III-IV (particularly, stage IV), T3-4, and high-grade malignancy. Of 18 deaths, causes were distant failure in 11 and local failure in 5. None died of nodal failure.<br> Analysis of these prognostic factors is important in selecting appropriate surgery and in determining indications for postoperative radiotherapy and chemotherapy, leading to better treatment outcome in those with parotid carcinoma.<br>
Journal
-
- Practica Oto-Rhino-Laryngologica
-
Practica Oto-Rhino-Laryngologica 103 (4), 349-356, 2010
The Society of Practical Otolaryngology
- Tweet
Keywords
Details 詳細情報について
-
- CRID
- 1390001204263663232
-
- NII Article ID
- 10026217152
-
- NII Book ID
- AN00107089
-
- ISSN
- 18844545
- 00326313
-
- NDL BIB ID
- 10643719
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed